Becton Dickinson & Co

BDX
As of the close on Sep 25, 2026
Price
$183.82
Market cap
$50.1B
P/E (diluted TTM)
55.5
EPS (TTM)
$3.31
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Becton Dickinson & Co Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: Becton Dickinson & Co — 10-Q filed Aug 6, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 19 annual periods. The latest annual period ends Sep 30, 2025. The latest insider filing shown is dated Jun 26, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Reported 13F positions

Each row shows what a filer reported for one date, not a current position. The link opens that filing.

Filer Report date Shares Value Filing
Chicago Capital, LLC 2026-03-31 1,321 $208K SEC filing
Cypress Wealth Services, LLC 2026-03-31 3,959 $622K SEC filing
Chemistry Wealth Management LLC 2026-03-31 12,908 $2.03M SEC filing
Atlantic Edge Private Wealth Management, LLC 2026-03-31 65 $10.2K SEC filing
INDEPENDENT FINANCIAL GROUP, LLC 2026-03-31 1,943 $305K SEC filing
Focus Partners Wealth 2026-03-31 949,473 $149M SEC filing
Pacific Capital Partners Ltd 2026-03-31 16,551 $2.6M SEC filing
State of Tennessee, Department of Treasury 2026-03-31 169,626 $26.7M SEC filing
Bank Julius Baer & Co. Ltd, Zurich 2026-03-31 578 $90.9K SEC filing
Banque de Luxembourg S.A. 2026-03-31 32,489 $5.11M SEC filing
JPMORGAN CHASE & CO 2026-03-31 3,570,324 $552M SEC filing
FOSTER & MOTLEY INC 2026-03-31 5,641 Not shown SEC filing
Burk Holdings LLC 2026-03-31 6 $943 SEC filing
Frec Markets, Inc. 2026-03-31 2,826 $444K SEC filing
BLAIR WILLIAM & CO/IL 2026-03-31 27,714 $4.36M SEC filing
SAX WEALTH ADVISORS, LLC 2026-03-31 1,749 $339K SEC filing
Curat Global, LLC 2026-03-31 500 $78.6K SEC filing
Koshinski Asset Management, Inc. 2026-03-31 6,729 $1.06M SEC filing
Southeast Asset Advisors, LLC 2026-03-31 2,028 $319K SEC filing
GREAT VALLEY ADVISOR GROUP, INC. 2026-03-31 3,213 $505K SEC filing
  • Each value is checked against Becton Dickinson & Co's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
  • Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Becton Dickinson & Co's share price.

120 filers have only one report here.

Unusually large insider trades

Each trade is compared with the other insider trades of the same kind in the same security among Becton Dickinson & Co's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.

  • 2026-06-01 · Polen Thomas E Jr: Larger than 45 of the 47 other insider sales of Common Stock on file. SEC filing
  • 2025-03-12 · Byrd Richard: Larger than 43 of the 47 other insider sales of Common Stock on file. SEC filing
  • 2024-12-19 · Garrison Michael David: Larger than 46 of the 47 other insider sales of Common Stock on file. SEC filing
  • 2024-12-06 · Goette Roland: Larger than all 47 other insider sales of Common Stock on file. SEC filing
  • 2023-11-28 · Byrd Richard: Larger than 44 of the 47 other insider sales of Common Stock on file. SEC filing

Purchases & sales (open market or private)

SecurityCodePriceFiling
2026-06-26Feld Michael · EVP, Chief Revenue OfficerCommon StockS — Open market or private sale−75152.80SEC filing
2026-06-24Garrison Michael David · EVP & Pres Med.Essntl&BioPharmCommon StockS — Open market or private sale−1,100145.66SEC filing
2026-06-10Garrison Michael David · EVP & Pres Med.Essntl&BioPharmCommon StockS — Open market or private sale−1,100151.48SEC filing
2026-06-01Polen Thomas E Jr · Chairman, CEO and PresidentCommon StockS — Open market or private sale−2,764146.35SEC filing
2026-05-26Feld Michael · EVP, Chief Revenue OfficerCommon StockS — Open market or private sale−75147.35SEC filing
2026-04-27Feld Michael · EVP, Chief Revenue OfficerCommon StockS — Open market or private sale−74151.94SEC filing
2026-03-26Feld Michael · EVP, Chief Revenue OfficerCommon StockS — Open market or private sale−75156.83SEC filing
2026-02-26Feld Michael · EVP, Chief Revenue OfficerCommon StockS — Open market or private sale−75181.84SEC filing

Showing 8 of 12 rows

Grants, exercises, tax & gifts

SecurityCodeFiling
2026-06-01Polen Thomas E Jr · Chairman, CEO and PresidentStock Appreciation RightsM — Exercise or conversion of derivative security−20,209SEC filing
2026-06-01Polen Thomas E Jr · Chairman, CEO and PresidentCommon StockM — Exercise or conversion of derivative security+20,209SEC filing
2026-06-01Menziuso Peter · EVP and President, BDICommon StockA — Grant, award, or other acquisition+14,258SEC filing
2026-05-08Huffines Robert Luther · DirectorRights to Common Stock Under BD Deferred Compensation PlanA — Grant, award, or other acquisition+210SEC filing
2026-05-08Byington Carrie L · DirectorRights to Common Stock Under BD Deferred Compensation PlanA — Grant, award, or other acquisition+105SEC filing
2026-05-07Roque Vitor · EVP & Chief Financial OfficerCommon StockA — Grant, award, or other acquisition+1,721SEC filing
2026-04-06Neal Shana Carol · EVP and Chief People OfficerCommon StockF — Payment of exercise price or tax by delivering securities−1,146SEC filing
2026-03-16Minnix Lanesha · EVP and General CounselCommon StockA — Grant, award, or other acquisition+7,492SEC filing

Showing 8 of 30 rows

Other activity

SecurityCodeFiling
2026-06-01Polen Thomas E Jr · Chairman, CEO and PresidentCommon StockD — Disposition to the issuer−17,445SEC filing
2026-01-15Garrison Michael David · EVP & Pres Med.Essntl&BioPharmCommon StockD — Disposition to the issuer−2,454SEC filing
2025-07-18Garrison Michael David · EVP & President, MedicalCommon StockD — Disposition to the issuer−5,175SEC filing
2024-12-06Goette Roland · EVP and President, EMEACommon StockD — Disposition to the issuer−9,490SEC filing
2024-08-14Goette Roland · EVP and President EMEACommon StockD — Disposition to the issuer−4,018SEC filing
2023-11-16 (amended)Goette Roland · EVP and President, EMEACommon StockD — Disposition to the issuer−2,233SEC filing

Showing 6 of 6 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.